Co-infection and Cancer (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-055 from the NIH Guide for Grants and Contracts. This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to co-infections (excluding co-infection with human immunodeficiency virus [HIV]) that engendered novel opportunities for prevention and treatment and focus on understudied populations. Coinfection is defined as the occurrence of infections by two or more infectious (pathogenic or nonpathogenic) agents either concurrently or sequentially and includes...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 14, 2022 Category: Research Source Type: funding
Rapid Translation of Epidemiological Findings into Interventions to Prevent Substance Use and Addiction (R61/R33 Clinical Trial Optional)
Funding Opportunity RFA-DA-24-010 from the NIH Guide for Grants and Contracts. The goal of this initiative is to address the structural incentives that limit translation from epidemiology into prevention science using a two-pronged approach. The phased R61/R33 mechanism will support innovative epidemiologic research using either primary data collection or analysis of existing data related to substance use and addiction in the R61 phase to provide the foundation for a targeted prevention intervention in the R33 phase. The R33 phase would apply the findings from the R61 phase to either a) adapt or target an existing inter...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 12, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Research to Address Ending the HIV Epidemic Initiative Goals Relevant to Substance Using Populations At-Risk for or Living with HIV
Notice NOT-DA-23-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 8, 2022 Category: Research Source Type: funding
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. Technologies proposed for development may be inte...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 2, 2022 Category: Research Source Type: funding
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. This FOA solicits R33 applications where major feasibility gaps for the technolog...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 2, 2022 Category: Research Source Type: funding
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 2, 2022 Category: Research Source Type: funding
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 2, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplement for Rapid Translation of Substance Use and Addiction Epidemiology and Prevention Intervention Research
Notice NOT-DA-24-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 1, 2022 Category: Research Source Type: funding
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-24-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch (MPIDB) and Office of AIDS Research (OAR). The goal of this initiative is to encourage applicants to leverage ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2022 Category: Research Source Type: funding
International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-067 from the NIH Guide for Grants and Contracts. This Funding opportunity Announcement (FOA) solicits applications for the International Centers of Excellence for Malaria Research (ICEMR) Program, a multidisciplinary network of centers that will conduct research in malaria-endemic sites to 1) improve our understanding of malaria pathogenesis, epidemiology, and transmission; and 2) evaluate, optimize, and inform development of interventions to understand, control, eliminate, and eventually eradicate malaria. This program is intended to support research that is conducted primarily in countrie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2022 Category: Research Source Type: funding
Notice of Need to Expire and Reissue RFA-ES-22-001 Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) to Clarify Review Criteria
Notice NOT-ES-23-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 4, 2022 Category: Research Source Type: funding
Learning Disabilities Research Centers (P50 Clinical Trial Optional)
Funding Opportunity RFA-HD-23-022 from the NIH Guide for Grants and Contracts. The Eunice Kennedy ShriverNational Institute of Child Health and Human Development (NICHD) invites center applications for the Learning Disabilities Research Centers Program, hereafter termed LDRCs. The LDRCs initiative focuses on generating new scientific knowledge to inform understanding of specific learning disorders (SLDs) and comorbid conditions through synergistic, integrated, team-based transdisciplinary science. This funding opportunity announcement invites both foundational and translational, transdisciplinary research addressing the...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 7, 2022 Category: Research Source Type: funding
NIH All About Grants Podcast – Phase III Trials
Dawn Corbett, M.P.H., NIH’s Inclusion Policy Officer
Christine Hunter, Ph.D., Acting Director of the Office of Behavioral and Social Sciences Research, NIH
NIH’s definition of a Phase III clinical trial is quite broad, including drug studies, device studies, behavioral interventions, epidemiological studies, community trials, and more. Phase III trials are usually large, prospective trials that compare two or more interventions against other standard or experimental interventions. In this next episode of our NIH All About Grants podcast (MP3 / Transcript) we explain what a Phase III trial is, how it compares to o...
Source: NIH Extramural Nexus - October 5, 2022 Category: Research Authors: NIH Staff Tags: New Resources Clinical Trials podcast valid analysis Source Type: funding
Notice of Change to PAR-22-162, "Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
Notice NOT-CA-22-134 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2022 Category: Research Source Type: funding
Notice of Change to PAR-22-161, "Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
Notice NOT-CA-22-133 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2022 Category: Research Source Type: funding
